Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy